Press - Illuminant

PRESS & MEDIA RESOURCES

Illuminant Surgical is transforming spine surgery through projection-based visualization technology that places critical anatomical information directly where surgeons need it most. Our press kit provides comprehensive information about our revolutionary Skylight system, which eliminates the cognitive disconnect between imaging and intervention while streamlining surgical workflow. For media inquiries or to arrange a demonstration, please contact our communications team at media@illuminant.ai.

May 30, 2025

Dr. James Hu Presents at Global Spine Congress 2025

Dr. James Hu, MD, co-founder of Illuminant Surgical, is presenting at the Global Spine Congress 2025 in Rio de Janeiro, Brazil.Together with Illuminant Surgical advisor, Dr. John Liu (Co-Director of Spine Surgery at the …

May 15, 2025

Illuminant Surgical Sponsors Global Spine Congress 2025

Illuminant Surgical is proud to sponsor the Global Spine Congress 2025!We’re excited to announce our participation in the upcoming Global Spine Congress 2025 as an official sponsor of this premier event in spine care. …

May 14, 2025

Podcast – Illuminant CEO on Building the First Real-time Anatomical Projection System

Our co-founder and CEO, Eldrick Millares, was recently interviewed on a podcast with AJ Fortier discussing the story behind Illuminant Surgical. Eldrick discusses his journey to build the world’s first real-time anatomical projection system for …

September 30, 2024

Illuminant Secures Grant Funding from the National Institutes of Health

Illuminant has been awarded a prestigious Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) - National Institute on Aging (NIA). This grant will support the development and …

January 20, 2024

Illuminant Wins NSF Grant for Spine Application

Illuminant Surgical has been awarded a competitive Phase 1 grant from the National Science Foundation (NSF) to further develop and validate its platform for spine surgery. This non-dilutive funding supports research into improving accuracy, …

January 14, 2024

Illuminant Partners with NVIDIA Inception

Illuminant has partnered with NVIDIA’s Inception Program, a platform designed to support cutting-edge AI and technology startups. Through this partnership, Illuminant gains access to advanced computational resources, engineering collaboration, and industry connections, accelerating the …

December 8, 2023

Illuminant Begins First Observational Study at Mount Sinai Hospital

Illuminant Surgical has launched its first observational study at Mount Sinai Health System in New York City. The study evaluates the usability and performance of Illuminant’s navigation system in live surgical environments. Following initial …

November 5, 2023

Peer-Reviewed Study: Illuminant Research Published in Journal of Medical Systems

Read the study at the Journal of Medical Systems. A study led by Illuminant’s clinical team has been published in the Journal of Medical Systems. The research provides groundbreaking insights into the economic barriers …

October 2, 2023

Illuminant Demonstrates Prototype to Mount Sinai Neurosurgery Leaders

Illuminant’s team recently traveled to New York City to showcase its platform to top neurosurgeons at Mount Sinai, including Chairman Dr. Joshua Bederson and Vice-Chair Dr. J Mocco. The demonstration highlighted Illuminant’s ability to …

September 13, 2023

Illuminant Presents Multiple Projects at Congress of Neurological Surgeons

Illuminant Surgical’s clinical research team presented multiple projects at the Congress of Neurological Surgeons (CNS) 2023 Annual Meeting. In an oral presentation, the team presented its findings on 3D-navigated procedures vs 2D-fluoroscopy guided procedures. …

FOUNDERS@ILLUMINANT.AI↗

5855 Green Valley Circle
Culver City, CA

The information presented on this website reflects the current development stage and intended capabilities of the Skylight Surgical Navigation System. Skylight has not been approved or cleared by the U.S. Food and Drug Administration (FDA) and is not available for sale or commercial use. No claims are made regarding the device’s safety or effectiveness.

HOME
PRODUCTS
PRESS
CAREERS
CONTACT

LINKEDIN
X / TWITTER
INSTAGRAM